Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...

Researchers from UConn's College of Agriculture, Health and Natural Resources (CAHNR) and College of Liberal Arts and ...

A new multinational study analyzing data from over 230 million people across 20 global sites highlights the relationship ...

The tantalising development has been reported by researchers at the Peter Doherty Institute for Infection and Immunity in ...

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, ...

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...

Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s ...

Researchers in Melbourne may have taken a major step toward an HIV cure after discovering a new way to unmask the virus ...

WASHINGTON — mRNA, a Nobel-winning technology harnessed by Trump officials to create Covid shots in record time, is becoming ...

Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of ...

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a new study.